Fabrication of PLA-PEG Nanoparticles as Delivery Systems for Improved Stability and Controlled Release of Catechin

被引:28
|
作者
Singh, Neha Atulkumar [1 ]
Mandal, Abul Kalam Azad [2 ]
Khan, Zaved Ahmed [1 ]
机构
[1] VIT Univ, Sch Biosci & Technol, Dept Integrat Biol, Vellore 632014, Tamil Nadu, India
[2] VIT Univ, Sch Biosci & Technol, Dept Biotechnol, Vellore 632014, Tamil Nadu, India
关键词
IN-VITRO; BIODEGRADABLE NANOPARTICLES; DRUG-RELEASE; ENCAPSULATION; TEA; ANTIOXIDANTS; MECHANISMS; ACID; VIVO;
D O I
10.1155/2017/6907149
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The purpose of this study was to develop an oral delivery system for the controlled release of catechin and evaluate the antioxidant potential and stability of catechin loaded PLA/PEG nanoparticles (CATNP). Nanoparticles were synthesized using a double emulsion solvent evaporation method. The fabricated nanoparticles were relatively small with a hydrodynamic diameter of 300 nm and an encapsulation efficiency of 95%. SEM image analysis showed uniform sized and spherically shaped nanoparticles. In vitro release profiles indicated a slow and sustained release of catechin from the nanoparticle. Stability of the nanoparticle in simulated gastric and intestinal fluids is maintained due to the PEG coating on the nanoparticles, which effectively protected catechin against gastrointestinal enzyme activity. Enhanced inhibition action of free radicals and metal chelation potential was noted when catechin was encapsulated in these polymeric nanoparticles. The reports obtained from this study would provide an opportunity for designing an oral delivery system aimed at inhibiting oxidative stress in the human body.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Intranasal delivery of zidovudine by PLA and PLA-PEG blend nanoparticles
    Mainardes, Rubiana Mara
    Khalil, Najeh Maissar
    Daflon Gremiao, Maria Palmira
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 395 (1-2) : 266 - 271
  • [2] Insulin Extended Release from PLA-PEG Stereocomplex Nanoparticles
    Shapira-Furman, Tovi
    Domb, Abraham J.
    MACROMOLECULAR BIOSCIENCE, 2024, 24 (05)
  • [3] Preparation and Characterization of Cationic PLA-PEG Nanoparticles for Delivery of Plasmid DNA
    Weiwei Zou
    Chunxi Liu
    Zhijin Chen
    Na Zhang
    Nanoscale Research Letters, 4
  • [4] Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel
    Angelopoulou, A.
    Voulgari, E.
    Diamanti, E. K.
    Gournis, D.
    Avgoustakis, K.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 93 : 18 - 26
  • [5] Preparation and Characterization of Cationic PLA-PEG Nanoparticles for Delivery of Plasmid DNA
    Zou, Weiwei
    Liu, Chunxi
    Chen, Zhijin
    Zhang, Na
    NANOSCALE RESEARCH LETTERS, 2009, 4 (09): : 982 - 992
  • [6] Core-shell structure of PLA-PEG nanoparticles used for drug delivery
    Riley, T
    Heald, CR
    Stolnik, S
    Garnett, MC
    Illum, L
    Davis, SS
    King, SM
    Heenan, RK
    Purkiss, SC
    Barlow, RJ
    Gellert, PR
    Washington, C
    LANGMUIR, 2003, 19 (20) : 8428 - 8435
  • [7] Predicting drug loading in PLA-PEG nanoparticles
    Meunier, M.
    Goupil, A.
    Lienard, P.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 526 (1-2) : 157 - 166
  • [8] Intravenous delivery of Erlotinib-loaded PLA-PEG nanoparticles for treatment of GB
    Hartman, Lauren K.
    Dhruv, Harshil D.
    Householder, Kyle T.
    Roth, Jeffrey E.
    Schorzman, Allison N.
    Zamboni, William
    Sirianni, Rachel
    Berens, Michael E.
    CANCER RESEARCH, 2016, 76
  • [9] Prolonged Release and Functionality of Interleukin-10 Encapsulated within PLA-PEG Nanoparticles
    Duncan, Skyla A.
    Dixit, Saurabh
    Sahu, Rajnish
    Martin, David
    Baganizi, Dieudonne R.
    Nyairo, Elijah
    Villinger, Francois
    Singh, Shree R.
    Dennis, Vida A.
    NANOMATERIALS, 2019, 9 (08)
  • [10] Defining the drug incorporation properties of PLA-PEG nanoparticles
    Govender, T
    Riley, T
    Ehtezazi, T
    Garnett, MC
    Stolnik, S
    Illum, L
    Davis, SS
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 199 (01) : 95 - 110